1. A new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from I to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 2 2 4 6 New Drug 1 2 2 3 7 Total Sample Old Drug (Ordered Smallest to R1=27.5 R2=27.5 a. We reject H9 in favor of H1, which states the two populations are not equal at the alpha equals .05 level because the calculated U value of 12.5 is greater than the critical U value of 2. b. We reject H0 in favor of H1, which states the two populations are not equal at the alpha equals .05 level because the calculated U value of 10.5 is greater than the critical U value of 2. c. We fail to reject Hp, which states the two populations are equal at the alpha equals .05 level because the calculated U value of 12.5 is greater than the critical Uvalue of 2. d. We fail to reject H0, which states the two populations are equal at the alpha equals .05 level because the calculated U value of 10.5 is greater than the critical Uvalue of 2. 2. A new chemotherapy drug is released to treat leukemia and researchers suspect that the drug may have fewer side effects than the mgstgggnngnlxused drug to treat leukemia. The two drugs have equivalent efcacy. _I_I_1__9_1:der__t_o determine if a larger study should be conducted to look into the prevalence of side effects for the two drugs, set up a Mann-Whitney U test at the alpha equals .05 level and interpret its results